Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Taki who wrote (129977)	3/17/2004 1:28:04 PM
From: tool dude	Read Replies (3) \| Respond to of 150070

geez tak ceo must be stoned to put that pr out

To: Taki who wrote (129977)	3/17/2004 1:40:31 PM
From: Taki	Read Replies (1) \| Respond to of 150070

DNAP.04.Bought more on the news,and forward looking event coming.(PR NEWSWIRE) DNAPrint(TM) Participates in the TBTF and BioFlorida Tampa Bay Pa tnering Conference Thursday, April 1, 2004 DNAPrint(TM) Participates in the TBTF and BioFlorida Tampa Bay Partnering Confer nce Thursday, April 1, 2004 SARASOTA, Fla., March 17 /PRNewswire-FirstCall/ -- DNAPrint's CEO and President is presenting at the combined Tampa Bay Technology Forum and BioFlorida Tampa Bay partnering conference on April 1, 2004 at the Hyatt Sarasota, 1000 Blvd. of the Arts, Sarasota, Florida. The presentation will include a description of DNAPrint(TM)'s technology and market applications. The presentation will highlight the four market segments in which DNAPrint(TM) applies its proprietary Single Nucleotide Polymorphism (SNP) screening technology: 1) genealogy; featuring its latest released product ANCESTRYbyDNA(TM) 2.5 used by genealogists and families to help understand their genetic heritage; 2) forensics; featuring its flagship product DNAWitness(TM) 2.0, which was introduced and first used in the first quarter of 2003 and has since helped detectives and investigators in two high-profile cases, the Louisiana serial killer case (2003) and the Concord, California case; 3) pharmacogenomics; the company is working with a Florida institution to advance its technology (known as Ovanome(TM)) and to combine its technology with other genetic methods to help reduce the risk of cancer treatment; and 4) contract genotyping; the company has developed a strong reputation as a reliable and cost-effective contract genotyping service and continues to supply medical centers and universities with this service. "We see the forum as a means to advance our company and improve shareholder value through partnering opportunities that might present themselves at this conference," said Richard Gabriel, CEO and President of DNAPrint(TM) genomics, Inc. "Over the last year we have been relatively quiet. We have spent this time reorganizing the company and advancing our technologies. We are seeking partners in all three commercial areas, genealogy, forensics and pharmacogenomics, and that could include partners in a variety of structures. We have just finished an $8.0 million financing round, and the proceeds from that transaction have been flowing into the company at a steady rate. This is the fuel that we need to build the business and advance the technology, and we are doing that." "The company's senior management will continue to explore all opportunities, and we believe these partnering forums are a great vehicle for allowing companies to exchange ideas and seek new opportunities," said Hector Gomez, MD, PhD, Chairman of the Board and Chief Medical Officer. "Our joining BioFlorida and being involved with the Sarasota business community is another step in advancing our technology and company," he said. "Sarasota and the Tampa Bay area are a rapidly emerging biotechnology center, and we were one of the first life-science companies to start up in Sarasota -- well, certainly one of the first genetics companies," said Tony Frudakis, PhD. "We're excited about the partnering opportunities that might exist in our own backyard." About DNAPrint(TM) genomics, Inc. DNAPrint(TM) genomics, Inc. was founded by a team of scientists with research and commercial experience in high-level mathematical modeling, programming and molecular genetics. The DNAWitness(TM) and the ANCESTRYbyDNA(TM) analysis is a direct result of focused research by the DNAP research and development team. In addition, using proprietary human genome research methods, the Company develops pharma-predictive tests for matching patients with drugs based on their genetic constitution, discovers disease genes for the development of new drugs and develops new forensic genomics and consumer genomics testing products. The Company is traded on the Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com. For more information on our genealogical DNA-derived test, ANCESTRYbyDNA(TM) 2.5, visit us on line at www.ancestrybydna.com helping everyone to understand their genetic heritage. All statements in this press release that are not historical and are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's(TM) products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint(TM) genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's(TM) expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Media and Press Contacts Richard Gabriel DNAPrint(TM) genomics, Inc. CEO/President (941) 366-3400 SOURCE DNAPrint(TM) genomics, Inc. -0- 03/17/2004 /CONTACT: Richard Gabriel, CEO - President, DNAPrint(TM) genomics, +1-941-366-3400/ /Web site: dnaprint.com ancestrybydna.com / (DNAP) CO: DNAPrint(TM) genomics, Inc. ST: Florida IN: MTC OTC SU: * end of story *

To: Taki who wrote (129977)	3/18/2004 10:17:29 PM
From: M0NEYMADE	Read Replies (1) \| Respond to of 150070

HELP! Martha Stewart needs us to write letters....more inside. source:msnbc.com Stewart asks friends to vouch for character As sentencing looms, the entrepreneur turns to friends for help. Meanwhile, her daughter says Stewart feels 'everything she did is being ignored over something that maybe didn't happen.' Martha Stewart is looking for friends to rally round and help with her sentencing. Stewart was found guilty of one count of conspiracy, two counts of making false statements and one count of obstruction of agency proceedings on March 5 and is scheduled to be sentenced on June 17. Your money, fast. In a letter to about 100 of her closest friends, obtained by The New York Daily News, the multimillionaire businesswoman says writing to the judge about her character is appropriate and would be helpful. The letter, headed “From the desk of … Martha Stewart” reads: Many people have inquired as to whether they can help by writing to Judge Cedarbaum about my sentence. I am advised by my lawyers that it is appropriate to do so, and that they believe Judge Cedarbaum will conscientiously read everything sent to her. If you would be so kind to write such a letter, please include your opinion of my character, my work ethic, my integrity and my probity. If possible, include any memorable experiences you have had with me to explain the basis of any expressed opinion(s). ... I deeply appreciate all of your good wishes and encouragement. Of course, your support means a great deal to me and my family. Still a chance at avoiding prison The letter campaign is a standard presentencing tactic, defense attorneys say, because Judge Miriam Goldman Cederbaum has great discretion under federal sentencing guidelines. Technically, Stewart faces up to five years in prison on each of the four convictions, but most legal experts predict a sentence of no more than 16 months, with part of that time served in a halfway house. -------------------------------------------------------------------------------- More Martha Stewart news and commentary on MSN Money • M.P. Dunleavey: Score one for the little guy • ‘Too smart to be guilty’ • Slate's guide to the Martha Stewart trial • Read all the recent news • Post your comments at the MSO Message Board • Read Stewart’s statement at MarthaTalks.com -------------------------------------------------------------------------------- But Stewart is expected to try to avoid prison altogether, and her letters are meant to show a life of 62 years of good deeds marred by a single indiscretion. She also plans an appeal of the convictions. On her Web site, Martha Talks, Martha Stewart tells her fans that she is "heartsick" but fully committed to her company, which has picked up her $4 million legal and public relations tab. "I will continue to provide creative inspiration for new product design and development, author two pending books (Homekeeping and Baking), make editorial contributions to our magazines and television programs, help build public profiles for the Company's core content experts, and provide input on the continuing evolution of the Company and its brands and on strategic issues," Stewart writes. The site has logged more than 30 million hits since last June and generated nearly 140,000 supportive e-mails, Stewart said, with more than 35,000 of them coming since the verdict on March 5. Supporters declared March 13 "Save Martha Day" and headed to Kmart (KMRT, news, msgs) to buy her Martha Stewart Living Everyday products. Apparently the effort paid off: Kmart, announcing its first post-bankruptcy profit, said today that the company had seen no "significant" impact on Stewart-branded housewares since the verdict. Daughter speaks out Last night, Stewart’s daughter Alexis told CNN’s Larry King that her mother feels her life was wasted and “everything she did is ignored over something that trivial, that maybe didn't happen." Stewart resigned from the board of Martha Stewart Living Omnimedia (MSO, news, msgs) on Monday, taking the new title of founding editorial director. Alexis Stewart, 38, told King her mother would not emerge from the ordeal bitter. "She's too, ironically, forgiving and kind and — I know people don't know that, but she was incredibly generous and she gives too much, I think," the daughter said. Alexis Stewart said she's not interested in taking over her mother's media empire, despite talk from supporters of the possibility. -- Kim Khan WOULD MARTHA WRITE A LETTER 2 SAVE YOUR ASSS. HAAHAHAAAAA...INSTEAD I SAY WRITE A LETTER STATING WHAT A POS SHE IS. REGARDS, MONEYMADE.